Sicurezza ed efficacia garantite del test rapido dell'antigene SARS-CoV-2 Lepu
-
2021-06-16
-
LEPU
Gentile cliente,
We are pleased to share with you the most updated news about our Test rapido dell'antigene SARS-CoV-2: Market performance follow-up studies have confirmed the safety and effectiveness of Lepu SARS-CoV-2 Antigen Rapid test.
Per monitorare e verificare continuamente le prestazioni di SARS-CoV-2 test Antigen Rapid, LEPU Medical Technology ha condotto diversi studi di follow-up delle prestazioni post mercato in Germania dopo aver ottenuto l'approvazione di BfArM per l'autotest.
The post market performance follow-up studies include the performance for layman and professionals respectively. The diagnostic sensitivity was 91.30%, and the specificity was 100% in the study done by Biomex in April 2021. The diagnostic sensitivity was 95.90%, and the specificity was 100% in the study done by Biomex in June 2021. The test results were both acceptable for layman and professionals.
Lepu fornirà costantemente prodotti innovativi e di alta qualità per continuare ad affrontare le esigenze mediche globali. Non esitate a farmi sapere se avete domande. Grazie!
Cordiali saluti,
Lepu Medical 
en.lepumedical.com
Follow us on social media
